Srk Life Sciences & Research (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 08-07-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 08-07-2024
- Revenue 49.28%
(FY 2022)
- Profit 143.43%
(FY 2022)
- Ebitda 179.76%
(FY 2022)
- Net Worth 1.76%
(FY 2022)
- Total Assets 0.54%
(FY 2022)
About Srk Life Sciences & Research (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹1.00 Cr.
Rajkumar Janakiraman, Sanjay Shahri, Kartikeya Uchila, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999KA2013PTC070163
- Company No.
070163
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2013
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Srk Life Sciences & Research (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Budiyar Rai  | Managing Director | 17-Jul-2013 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajkumar Janakiraman | Director | 17-Jul-2013 | Current |
| Sanjay Shahri | Director | 17-Jul-2013 | Current |
| Kartikeya Uchila | Director | 17-Jul-2013 | Current |
| Humchadakatte Malathesh | Director | 05-Nov-2013 | Current |
| Rithesh Rai | Director | 25-Sep-2015 | Current |
Financial Performance of Srk Life Sciences & Research (India).
Srk Life Sciences & Research (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.28% increase. The company also saw a substantial improvement in profitability, with a 143.43% increase in profit. The company's net worth moved up by a moderate rise of 1.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srk Life Sciences & Research (India)?
In 2020, Srk Life Sciences & Research (India) had a promoter holding of 47.00% and a public holding of 53.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Octaplus Medicare Solutions Private LimitedActive 8 years 8 monthsBudiyar Rai and Humchadakatte Malathesh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 04 Aug 2014 | ₹1.00 Cr | Open |
How Many Employees Work at Srk Life Sciences & Research (India)?
Srk Life Sciences & Research (India) has a workforce of 13 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srk Life Sciences & Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srk Life Sciences & Research (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
